PubMed HealthSearch

Biomedical subjects

E P Mueller

Publications and source records attributed to E P Mueller.

4 recordsLinked to original sources

Reference standards for implantable materials: problems and needs.

Medical implant materials that come in contact with tissues, body fluids (including blood) constitute an area in medical devices where reliability and clinical performance limitations are vital. Polymeric implant materials differ in important aspects from metals and alloys, and ceramics (including glasses and carbons) with respect to their atomic and molecular structures and morphology. It is suggested that four categories of 'standards' be developed: (1) certified primary reference materials to be used for calibration purposes, (2) reference materials to be used for the comparative evaluation of physico-chemical and biological properties, (3) 'fabrication-grade' reference materials for intercomparative evaluation of processing conditions, and (4) reference implants aimed at the intercomparative evaluation of possible synergistic effects of additives, processing aids, and fabrication processes on in vivo service life, including biological and mechanical performance.

Biocompatible Materials

Radiation sterilization of polymeric implant materials.

High-energy irradiation sterilization of medical devices and implants composed of polymeric biomaterials that are in contact with tissue and/or blood, may adversely affect their long-term mechanical and/or biological performance (tissue and/or blood compatibility). Since many polymeric implants may contain trace quantities of catalysts and/or other additives, the effect of high-energy radiation on these additives, and possible synergistic effects with the polymer chains under the influence of high-energy radiation, must be considered. It is essential to indicate whether polymeric implants are used in short-term (acute) or long-term (chronic) applications. Relatively small changes in their physicochemical, mechanical, and biological properties may be tolerable in the short term, whereas similar changes may lead to catastrophic failures in long-term applications. Therefore, polymeric implants which are to be sterilized by high-energy irradiation should be carefully evaluated for long-term property changes which may be induced by the radiation.

Biocompatible Materials

Materials and biological aspects of synthetic polymers in controlled drug release systems: problems and challenges.

The physico-chemical and biological aspects of polymeric materials represent vital areas in the reliable, safe, and efficacious functioning of controlled drug-delivery devices. In the case of implantable systems, potential biological problems include incompatibility of the polymers and their degradation products with the physiological environment, adverse metabolic consequences of the degradation products, and occlusion of the drug conduits (catheters) with thrombi and/or drugs, (i.e., insulin aggregates). In the case of transcutaneous drug delivery systems, proper consideration must be given to avoid skin irritation and allergic responses as well as other toxic effects. With biodegradable systems that may follow simple hydrolysis and/or enzyme-catalyzed degradation of labile chemical side-chains that hold the drug molecule and/or the main polymer chain, increased attention must be given not only to the short-term but also the long-term metabolic consequences of the degradation products. Although the term "biodegradation" is often used for in vitro situations it should be reserved only for in vivo circumstances as, at the present time, no in vitro experiments can completely simulate the in vivo environment. The misuse of this term may lead to premature predictions as to the performance of a device in vivo, a situation that ought to be avoided. Appropriate attention must also be given to the effect of drugs on polymers as drug/polymer interactions may influence the stability of both the polymers and drugs and may result in altered therapeutic performance. Standards are needed to clearly differentiate between controlled drug delivery systems and older "sustained" and "time-release" preparations.

Biodegradation, Environmental

Materials aspects of implantable cardiac pacemaker leads.

The reliability of the leads of the entire pacemaker system is vital as the risks of failure include: (1) loss of pacing due to the deterioration of the polymeric insulator in the physiological environment; (2) thromboembolism due to inadequate blood compatibility of the insulator; (3) tissue reactions at the electrode/tissue interface; (4) general foreign body rejection phenomena; (5) perforation of the leads; and (6) excessive stress applied by sutures causing abrasion and stress cracking. Although silicone has been used widely, some years ago Pellethane (a segmented polyetherurethane-urea) has been introduced as an alternate lead insulator, chiefly because it can be extruded using additives into smooth and thin tubes. The additives (antioxidants), extrusion aids, and low molecular weight polymer chains (oligomers) together represent up to approximately 8% by weight of leachables, depending on the extraction medium. The in vivo degradation of Pellethane is biologic in nature and is most likely associated with the absorption and premeation of body fluids from the surrounding physiologic environment leading to stress cracking via the formation of microvoids. Thermally and biologically unstable biuret and allophonate groups in this polyurethane, exposure of the polymer to high extrusion temperatures, and stresses created within the polymer also play key roles in the degradation process. In the case of electrodes, some corrosion can occur even with noble metals and ions formed with the involvement of penetrating body fluids which may combine with the urethane and/or urea groups of the polyurethane, leading to its further degradation in vivo. The totality of the situation indicates a need for the development of a standard guideline for the uniform and consistent pre-clinical testing and evaluation of new materials and fabrication processes of implantable pacemaker leads. Such guidelines should take into consideration, among others, the physiological environment, species-differences between test animals and humans, and observe reliable statistical interpretations based on sufficient data.

Electrocardiography